Change in Weight from Baseline with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Services
Services
Date issued
2014Journal title
Arthritis and Rheumatology
Type of content
Publicación de congreso
